Showing results (251-260 of 482) with videos related to
Sort By:
Pageof 49
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1997
Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesteroneK Lippuner, W Haenggi, M H Birkhaeuser, et al.American Journal of Nephrology|January 1, 1985
Evidence for a particularly severe secondary hyperparathyroidism in analgesic abuse nephropathyP Jaeger, P Burckhardt, J P Wauters, et al.Schweizerische Medizinische Wochenschrift|December 4, 1982
[Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse]P Jaeger, P Burckhardt, J P Wauters, et al.Der Urologe. Ausg. A|May 1, 1989
[The staghorn calculus: anatrophic nephrolithotomy versus percutaneous litholapxy and extracorporeal shockwave therapy versus extracorporeal shockwave lithotripsy monotherapy. A report of over 6 years' experience]F Recker, K Konstantinidis, P Jaeger, et al.Neuropsychobiology|January 31, 2019
Could Dietary Glutamate Play a Role in Psychiatric Distress?A Zarina Kraal, Nicole R Arvanitis, Andrew P Jaeger, et al.Ultrasonic Imaging|October 1, 1985
Quantitative assessment of in vivo backscatter enhancement from gelatin microspheresJ Ophir, A Gobuty, N Maklad, et al.Schweizerische Medizinische Wochenschrift|March 8, 1986
[Optimal dosage of chlorthalidone in the prevention of the recurrence of nephrolithiasis is 25 mg per day]P Jaeger, L Portmann, A F Jacquet, et al.Schweizerische Medizinische Wochenschrift|November 15, 1975
[Value and limits of the determination of carcinoembryonic antigen (CEA) in postoperative evaluation of patients with colonic and rectal carcinomas]P Jaeger, J Pettavel, B Wuilleret, et al.European Journal of Internal Medicine|June 8, 2001
Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurementsJ -P. Casez, R Pfammatter, Q -V. Nguyen, et al.Clinical Nephrology|May 1, 1993
Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patientsJ A Fuhrer, A Montandon, C Descoeudres, et al.Pageof 49